Health Press Barbados: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Press Barbados.

Press releases published on June 30, 2026

33 minutes ago

Unicycive Therapeutics Receives Complete Response Letter from FDA Regarding Resubmitted Oxylanthanum Carbonate (OLC) New Drug Application (NDA)

Indeterminate GlobeNewswire

38 minutes ago

AC Immune Reports Interim 12-Month Data from Phase 1b/2 ABATE Trial of ACI-24 in Prodromal Alzheimer’s Disease

Indeterminate GlobeNewswire

38 minutes ago

R1 Therapeutics establishes world-class Scientific Advisory Board to support advancement of AP306 in Chronic Kidney Disease

Indeterminate GlobeNewswire

38 minutes ago

Beeline Medicines Announces Upsized Series A of $426.3 Million to Advance Category-Leading Autoimmune and Inflammatory Disease Portfolio

Indeterminate GlobeNewswire

38 minutes ago

Tilray Beer Brands SweetWater, 10 Barrel, Breckenridge, BrewDog, Montauk, Blue Point, Hop Valley and Terrapin Tap into America’s 250th with Fourth of July Celebrations Nationwide

Indeterminate GlobeNewswire

38 minutes ago

Solana Company Partners with Alatau City to Advance Digital Asset Infrastructure and Blockchain Adoption in Central Asia

Indeterminate GlobeNewswire

38 minutes ago

Pasithea Therapeutics Announces Positive Interim Phase 1 Advanced Cancer Study Data Demonstrating Long-Term Safety and Tolerability, and Durable Clinical Activity in MEK/BRAF-Pretreated Patients, plus Protocol Expansion

Indeterminate GlobeNewswire

2 hours ago

Intravacc Makes Qualified Vero Cell Banks Available to Accelerate Viral Vaccine Development

Indeterminate GlobeNewswire

2 hours ago

Intravacc Highlights Four Integrated Vaccine Development Platforms for CDMO Partners

Indeterminate GlobeNewswire

2 hours ago

Salipro Biotech Announces Publication in Nature Scientific Reports on Expanding DEL Screening to Membrane Proteins

Indeterminate GlobeNewswire

3 hours ago

HUTCHMED to Announce 2026 Half-Year Financial Results

Indeterminate GlobeNewswire

3 hours ago

Nxera Pharma to Receive US$10 Million Milestone Payment from AbbVie under Collaboration Targeting Neurological Diseases

Indeterminate GlobeNewswire

4 hours ago

smartbax secures additional financing to advance lead antibiotic program to IND filing

Indeterminate GlobeNewswire

5 hours ago

American Idol, The Voice Finalists Lend Their Voices To Special Holiday Anthem Benefiting Childhood Cancer Warriors

Indeterminate GlobeNewswire

6 hours ago

AdJane Reports First Clinical Validation of its OMV Vaccine Platform Inducing Mucosal Immunity in Humans

Indeterminate GlobeNewswire

7 hours ago

Addex Shareholders Approve All Resolutions at Annual General Meeting

Indeterminate GlobeNewswire

7 hours ago

Press Release: Sanofi’s Nexviazyme met all primary and secondary endpoints in infantile-onset Pompe disease phase 3 study

Indeterminate GlobeNewswire

7 hours ago

Communiqué de presse : Le Nexviazyme de Sanofi a atteint tous les critères d’évaluation principaux et secondaires dans une étude de phase III sur la forme infantile de la maladie de Pompe

Indeterminate GlobeNewswire

9 hours ago

Nuvectis Pharma Announces Pricing of $100 Million Public Offering of Common Stock

Indeterminate GlobeNewswire